DANIEL S WOLOSHEN Insider Trading
Get free email notifications about insider trading for DANIEL S WOLOSHEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DANIEL S WOLOSHEN. DANIEL S WOLOSHEN is a Senior VP and General Counsel in rEVO Biologics, Inc. ($GTCB) and a SVP and General Counsel in rEVO Biologics, Inc. ($GTCB).
Address: C/O GTC BIOTHERAPEUTICS, INC. 175 CROSSING BOULEVARD FRAMINGHAM 01702 MA
Companies in which DANIEL S WOLOSHEN is an Insider
rEVO Biologics, Inc.
Trading Symbol: GTCBIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DANIEL S WOLOSHEN: Senior VP and General Counsel, SVP and General Counsel
Holdings: 22,033 shares
Latest Transaction: Nov 04 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of DANIEL S WOLOSHEN
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 04 2009 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | Senior VP and Gener ... | Grant | A | 1.21 | 11,717 | 14,178 | 22,033 | 10.3 K to 22 K (+113.58 %) |
Jul 02 2009 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | Senior VP and Gener ... | Payment of Exercise | F | 2.66 | 1,165 | 3,099 | 10,316 | 11.5 K to 10.3 K (-10.15 %) |
Apr 01 2009 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | Senior VP and Gener ... | Option Exercise | A | 0.37 | 35,000 | 12,950 | 35,000 | |
Feb 05 2009 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | Senior VP and Gener ... | Grant | A | 0.00 | 5,400 | 0 | 114,825 | 109.4 K to 114.8 K (+4.93 %) |
Dec 11 2008 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | Senior VP and Gener ... | Option Exercise | A | 0.31 | 100,000 | 31,000 | 100,000 | |
Jul 03 2008 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | Senior VP and Gener ... | Grant | A | 0.00 | 30,600 | 0 | 109,425 | 78.8 K to 109.4 K (+38.82 %) |
Mar 12 2008 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | Senior VP and Gener ... | Sell | S | 0.57 | 17,000 | 9,699 | 78,825 | 95.8 K to 78.8 K (-17.74 %) |